FI832832A0 - Substituerad 9-(1-0- eller 3-0-monosubstituerad eller 1,3-d1-0-substituerad propoxymetyl)-puriner som antiviral agenter - Google Patents

Substituerad 9-(1-0- eller 3-0-monosubstituerad eller 1,3-d1-0-substituerad propoxymetyl)-puriner som antiviral agenter

Info

Publication number
FI832832A0
FI832832A0 FI832832A FI832832A FI832832A0 FI 832832 A0 FI832832 A0 FI 832832A0 FI 832832 A FI832832 A FI 832832A FI 832832 A FI832832 A FI 832832A FI 832832 A0 FI832832 A0 FI 832832A0
Authority
FI
Finland
Prior art keywords
sup
eller
carbon atoms
hydrogen
antiviral
Prior art date
Application number
FI832832A
Other languages
English (en)
Other versions
FI832832A (fi
FI74006B (fi
FI74006C (fi
Inventor
Julien Pierre Henri Verheyden
John Charles Martin
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of FI832832A0 publication Critical patent/FI832832A0/fi
Publication of FI832832A publication Critical patent/FI832832A/fi
Publication of FI74006B publication Critical patent/FI74006B/fi
Application granted granted Critical
Publication of FI74006C publication Critical patent/FI74006C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/174Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1745Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/178Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI832832A 1982-08-09 1983-08-08 Foerfarande foer framstaellning av antivirala substituerade 9(1-0- eller 3-0-monosubstituerad- eller 1,3-di-0-substituerad propoximetyl)guaniiner. FI74006C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40658382 1982-08-09
US06/406,583 US4556659A (en) 1982-08-09 1982-08-09 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents

Publications (4)

Publication Number Publication Date
FI832832A0 true FI832832A0 (fi) 1983-08-08
FI832832A FI832832A (fi) 1984-02-10
FI74006B FI74006B (fi) 1987-08-31
FI74006C FI74006C (fi) 1987-12-10

Family

ID=23608623

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832832A FI74006C (fi) 1982-08-09 1983-08-08 Foerfarande foer framstaellning av antivirala substituerade 9(1-0- eller 3-0-monosubstituerad- eller 1,3-di-0-substituerad propoximetyl)guaniiner.

Country Status (15)

Country Link
US (1) US4556659A (fi)
EP (1) EP0105135B1 (fi)
JP (1) JPS5948483A (fi)
KR (1) KR890000811B1 (fi)
AT (1) ATE25980T1 (fi)
AU (1) AU571451B2 (fi)
DE (1) DE3370331D1 (fi)
DK (1) DK361383A (fi)
ES (2) ES8603185A1 (fi)
FI (1) FI74006C (fi)
HU (1) HU193530B (fi)
IE (1) IE55843B1 (fi)
NO (1) NO162469C (fi)
NZ (1) NZ205171A (fi)
ZA (1) ZA835799B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
US4609661A (en) * 1982-08-09 1986-09-02 Syntex (U.S.A.) Inc. Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted propoxymethyl)purines as antiviral agents
FI74468C (fi) * 1982-10-14 1988-02-08 Wellcome Found Foerfarande foer framstaellning av terapeutiskt aktiva 2-aminopurinderivat.
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
DE4002792A1 (de) * 1990-01-31 1991-08-01 Teves Gmbh Alfred Vorrichtung zur ermittlung der beschaffenheit einer druckuebertragungsfluessigkeit
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
CN110026212B (zh) * 2019-05-23 2022-03-04 临海市利民化工有限公司 一种裂解催化剂及使用该催化剂制备西他沙星中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
NO158539C (no) * 1981-08-11 1988-09-28 Wellcome Found Analogifremgangsmaate for fremstilling av en terapeutisk aktiv 2,6-diaminopurinforbindelse.
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation

Also Published As

Publication number Publication date
NO162469B (no) 1989-09-25
ES545261A0 (es) 1986-01-01
FI832832A (fi) 1984-02-10
DK361383A (da) 1984-02-10
DE3370331D1 (en) 1987-04-23
FI74006B (fi) 1987-08-31
KR840006007A (ko) 1984-11-21
KR890000811B1 (ko) 1989-04-08
AU571451B2 (en) 1988-04-21
IE55843B1 (en) 1991-01-30
ES524811A0 (es) 1986-01-01
IE831867L (en) 1984-02-09
AU1768383A (en) 1984-02-16
NO162469C (no) 1990-01-10
HU193530B (en) 1987-10-28
JPS5948483A (ja) 1984-03-19
ES8603186A1 (es) 1986-01-01
DK361383D0 (da) 1983-08-08
EP0105135A1 (en) 1984-04-11
US4556659A (en) 1985-12-03
EP0105135B1 (en) 1987-03-18
FI74006C (fi) 1987-12-10
ES8603185A1 (es) 1986-01-01
ATE25980T1 (de) 1987-04-15
ZA835799B (en) 1984-04-25
NZ205171A (en) 1987-05-29
NO832842L (no) 1984-02-10

Similar Documents

Publication Publication Date Title
ES8504194A1 (es) Procedimiento para preparar 9-(1 o 3-monoaciloxi-o 1,3-diaciloxi-2-propoximetil)-purinas substituidas en calidad de agentes antiviricos.
FI832832A (fi) Substituerad 9-(1-0- eller 3-0-monosubstituerad eller 1,3-d1-0-substituerad propoxymetyl)-puriner som antiviral agenter
PE31691A1 (es) Procedimiento para la preparacion de nuevos compuestos fungicidas
ES2081308T3 (es) Nucleosidos fosfolipidos.
ES2000346A6 (es) Un procedimiento para la preparacion de derivados de distamicina
ES2020508B3 (es) Derivados citoprotectores utiles para enfermedades isquemicas, su preparacion y composiciones que los contienen.
ES483854A1 (es) Proceso para la obtencion de un derivado de 2-deoxi-5-fluo- rouridina.
ES451235A1 (es) Un procedimiento para la preparacion de una composicion de- tergente.
ES471268A1 (es) Procedimiento para la preparacion de derivados alfa-acetile-nicos de alfa-amino acidos
ES2181269T3 (es) Compuestos analogos a fosfolipidos.
BR8500851A (pt) Processo para produzir um derivado de benzoilureia e processo para produzir uma composicao inseticida e/ou ovicida
ATE50773T1 (de) Alkylresorcinolphosphite.
BR8606955A (pt) Processo para preparar uma composicao,concentrado aditivo,composicao lubrificante,composicao combustivel e metodo para reduzir o consumo de combustivel
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
ES8306378A1 (es) "un procedimiento para la preparacion de derivados de adenosina".
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
ES8203917A1 (es) Un procedimiento para la preparacion de un derivado de nu- cleosido de adenina
DK0417449T3 (da) Arylpyrazolderivater som blodpladeaggregationsinhibitorer
DK405579A (da) N-(1,2-azolyl)-alkyl-halogenacetanilider deres fremstilling og anvndelse i og som herbicide midler samt n-(1,2-azolyl)-alkyl-aniliner (mellemprodukter) og disses fremstilling
PE42998A1 (es) Derivados 1,25-dihidroxi-16,22,23-tridehidro-colecalciferol
GB1457245A (en) Cyclohexenyl compounds
US4206146A (en) 2-Decarboxy-2-aminomethyl-trans-2,3-didehydro-9-deoxy-9-methylene-PGF compounds
ATE16797T1 (de) 1-(3,4-bis-(3-(alkoxycarbonyl)-2-thioureido)phenyl-1-phenylethylen.
EP0123739A3 (en) Alpha-substituted-alkylarylketals particularly useful for preparing alpha-arylalkanoic acids

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SYNTEX (U.S.A.) INC.